General Biosystems

General Biosystems is a synthetic biology company that provides high-throughput gene synthesis and DNA assembly services to the global life sciences community. The company utilizes proprietary technology to manufacture custom DNA constructs, gene libraries, and complex molecular biology products with high precision and speed. Based in the Research Triangle Park area of North Carolina, General Biosystems serves as a critical partner for researchers in drug discovery, agricultural biotechnology, and industrial microbiology. Following its acquisition by GenScript Biotech Corporation in 2018, the company has expanded its capacity to support large-scale genomic projects and synthetic biology applications. Its services are designed to accelerate the design-build-test cycle for synthetic biology, enabling faster innovation in therapeutic development and bio-manufacturing.